SBFMSunshine Biopharma, Inc.

$6M

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$136,939

Gross Profit

$34,13724.9% margin

Operating Income

-$288,825-210.9% margin

Net Income

-$907,556-662.7% margin

EPS (Diluted)

$-18.15

QoQ Revenue Growth

+27.7%

Cash Flow

Operating Cash Flow

-$103,861

Free Cash Flow

-$108,861

Stock-Based Comp.

$171,000

Balance Sheet

Total Assets

$1M

Total Liabilities

$1M

Stockholders' Equity

$44,663

Cash & Equivalents

$46,430

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$136,939	$0	—
Gross Profit	$34,137	-$16,800	+303.2%
Operating Income	-$288,825	-$113,805	-153.8%
Net Income	-$907,556	-$147,611	-514.8%

SBFM Q3 2018 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena